Global logistics company UPS has announced that it has completed the acquisition of Frigo-Trans and its sister company BPL, which provide complex healthcare logistics solutions across Europe.
UPS says that these acquisitions ‘further enhance the end-to-end capabilities available to UPS Healthcare customers, who increasingly need temperature-controlled and time-critical logistics solutions globally’.
Headquartered in Fußgönheim, Germany, Frigo-Trans provides an end-to-end warehouse and transportation solution for pharmaceutical and biotech customers, with a ‘pharmacy-focused, Pan-European cold chain transportation network’. It also provides value-added services such as packaging, handling and inventory management.
Also based in Germany but headquartered in Düsseldorf, BPL offers ‘individual transport management for GDP-compliant shipping of time-critical and temperature-sensitive products’. It manages a network of air and ocean freight carriers along with customs clearance to ‘meet the complex, cross-border needs of customers’.
UPS announced that it had agreed to acquire Frigo-Trans in September 2024, describing the acquisition as ‘crucial for healthcare customers as it strengthens UPS’s capacity to manage temperature-sensitive and time-critical pharmaceutical logistics, ensuring more efficient and reliable cold chain solutions’.
At the time of the announcement, Kate Gutmann, UPS’ executive vice president and president of international, healthcare and supply chain solutions, commented: “The fast-paced innovation in the pharmaceutical industry is creating the need to have more integrated cold and frozen supply chains.
“Frigo-Trans will help deepen our portfolio of solutions and accelerate our journey to become the number-one complex healthcare logistics provider in the world.”
